NMD Pharma

Risskov, Denmark

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

$81.4M raised

Nov 2023

Series B

Top Investors

Jeito CapitalNovo HoldingsInkefRoche Venture FundCAPNOVA

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NMD Pharma raised?

NMD Pharma has raised $81.4M in total funding. The most recent round was Series B. The last funding was announced in November 2023.

Who are NMD Pharma's investors?

NMD Pharma's investors include Jeito Capital, Novo Holdings, Inkef, Roche Venture Fund, CAPNOVA.

Where is NMD Pharma headquartered?

NMD Pharma is headquartered in Risskov, Denmark.

What does NMD Pharma do?

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

What stage is NMD Pharma at?

NMD Pharma is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2023.

MLA

"NMD Pharma — Funding & Investors." VCBacked, November 15, 2023, https://www.vcbacked.co/company/nmd-pharma. Accessed June 7, 2026.

APA

VCBacked. (2023). NMD Pharma — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/nmd-pharma

Wikipedia (cite web)

{{cite web |title=NMD Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nmd-pharma |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2023.